Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Diantha B, Howard"'
Autor:
Rup Tandan, Evan A Levy, Diantha B Howard, John Hiser, Nathan Kokinda, Swatee Dey, Edward J Kasarskis
Publikováno v:
Am J Clin Nutr
BACKGROUND: Motor neuron degeneration and malnutrition alter body composition in amyotrophic lateral sclerosis (ALS). Resulting losses of weight, fat mass (FM), and fat-free mass (FFM) shorten survival. Nutritional management relies on body weight or
Autor:
Richard Nowak, Michael Benatar, Diantha B. Howard, Shane M. Greene, Aditya Kumar, Brian A. Crum, Rachel Beekman, Katherine M Clifford, Michael Pulley, Carolina Barnett, Melissa A. Fellman, Richard J. Barohn, I-Hweii Amy Chen, Katherine Ruzhansky, Shannon M. Laboy, Michael K. Hehir, James F. Howard, Mamatha Pasnoor, Amy Visser, Ted M. Burns, Nicholas Silvestri, Noah Kolb, Mazen M. Dimachkie, Lisa D. Hobson-Webb
Publikováno v:
Muscle & Nerve. 59:404-410
Introduction A randomized trial demonstrated benefit from thymectomy in nonthymomatous acetylcholine receptor (AChR)-antibody positive myasthenia gravis (MG). Uncontrolled observational and histologic studies suggest thymectomy may not be efficacious
Autor:
Hiroshi Mitsumoto, Diantha B. Howard, Mark B. Bromberg, Dwight E. Matthews, Edward J. Kasarskis, Rup Tandan, Connor N Scagnelli, Zachary Simmons
Publikováno v:
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 19:220-231
We present a study of hydration in ALS patients and its effects on survival. This was a multicenter study over 48 weeks in 80 ALS patients who underwent 250 individual measurements using doubly labeled water (DLW). Total body water (TBW) and water tu
Autor:
Susan L. Beck, Noah Kolb, Diantha B. Howard, J. Singleton, Kathi Mooney, A. Smith, Summer Karafiath, Kim Dittus
Publikováno v:
Supportive Care in Cancer. 26:1607-1615
The purpose of this study was to evaluate a new care model to reduce chemotherapy-induced neuropathic symptoms. Neuropathic symptom usual care was prospectively compared to an automated symptom-monitoring and coaching system, SymptomCare@Home (SCH),
Publikováno v:
Muscle & Nerve. 56:185-196
Rituximab is a chimeric mouse/human anti-CD20 monoclonal immunoglobulin. We reviewed the efficacy and safety of rituximab in 169 myasthenia gravis (MG) patients from case reports and series. Antibodies to the acetylcholine receptor (AChR) were presen
Publikováno v:
Journal of food protection. 52(10)
The infectious dose of Listeria monocytogenes F5817, a serotype 4b human patient isolate, was determined following oral challenge in normal and compromised C57B1/6J mice. In an attempt to mimic human populations previously shown to be at risk to inge
Publikováno v:
Journal of food protection. 49(12)
Milk from bulk tanks of 2,931 dairy herds were sampled and evaluated using trypticase blood-esculin agar, somatic cell, standard plate and preliminary incubation counts. Percent samples with trypticase blood-esculin agar counts >1 × 102 colony formi
Autor:
Andrew J. Solomon, Pascal Sati, Richard Watts, Joshua P. Nickerson, Daniel S. Reich, Diantha B. Howard, Matthew K. Schindler
Publikováno v:
Annals of Clinical and Translational Neurology
Objective The diagnosis of multiple sclerosis (MS) presently relies on radiographic assessments of imperfect specificity. Recent data using T2* methodology for the detection of the “central vessel sign” (CVS) in MS lesions suggests this novel MRI
Autor:
Michael Benatar, Aditya Kumar, Brian A. Crum, Rachel Beekman, Shannon M. Laboy, Michael Pulley, Richard Nowak, Mamatha Pasnoor, Amy Visser, Carolina Barnett, Lisa D. Hobson-Webb, Shane M. Greene, Katherine Ruzhansky, I-Hweii Amy Chen, Ted M. Burns, Melissa A. Fellman, Diantha B. Howard, James F. Howard, Michael K. Hehir, Nicholas Silvestri
Publikováno v:
Neurology. 89(10)
Objective:To evaluate the efficacy of rituximab in treatment of anti-muscle-specific kinase (MuSK) myasthenia gravis (MG).Methods:This was a multicenter, blinded, prospective review, comparing anti-MuSK-positive patients with MG treated with rituxima
Publikováno v:
Musclenerve. 56(2)
Rituximab is a chimeric mouse/human anti-CD20 monoclonal immunoglobulin. We reviewed the efficacy and safety of rituximab in 169 myasthenia gravis (MG) patients from case reports and series. Antibodies to the acetylcholine receptor (AChR) were presen